Saptalis Pharms Company Profile

✉ Email this page to a colleague

SAPTALIS PHARMS has sixteen approved drugs.

There is one US patent protecting SAPTALIS PHARMS drugs.

There are five patent family members on SAPTALIS PHARMS drugs in five countries and seventy-two supplementary protection certificates in fifteen countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Saptalis Pharms	POTASSIUM CHLORIDE	potassium chloride	SOLUTION;ORAL	211648-001	May 21, 2021	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Saptalis Pharms	ACETIC ACID	acetic acid, glacial	SOLUTION/DROPS;OTIC	040607-001	Feb 24, 2005	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Saptalis Pharms	LEVOCARNITINE	levocarnitine	SOLUTION;ORAL	212533-001	Nov 10, 2021	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Saptalis Pharms	LITHIUM CITRATE	lithium citrate	SYRUP;ORAL	217183-001	Feb 29, 2024	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Saptalis Pharms	LOPERAMIDE HYDROCHLORIDE	loperamide hydrochloride	SOLUTION;ORAL	074352-001	Nov 17, 1995		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Saptalis Pharms	CLOBETASOL PROPIONATE	clobetasol propionate	SOLUTION;TOPICAL	211494-001	Oct 2, 2019	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Brazil	112020014376	⤷ Try a Trial
European Patent Office	3768321	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2019140516	⤷ Try a Trial
Mexico	2020007494	⤷ Try a Trial
Canada	3087789	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1441735	SPC/GB08/020	United Kingdom	⤷ Try a Trial	PRODUCT NAME: RALTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; REGISTERED: UK EU/1/07/436/001 20080102
0799044	02C0040	France	⤷ Try a Trial	PRODUCT NAME: OLOPATADINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/02/217/001 20020517
1730131	C01730131/02	Switzerland	⤷ Try a Trial	PRODUCT NAME: EMPAGLIFLOZIN UND METFORMINHYDROCHLORID; REGISTRATION NO/DATE: SWISSMEDIC 65570 12.11.2015
1441735	2008/010	Ireland	⤷ Try a Trial	PRODUCT NAME: RALTEGRAVIR OR A PHARMECEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; NAT AUTHORISTION NO/DATE: EU/1/07/436/001-002 20071220;
2498758	CA 2020 00017	Denmark	⤷ Try a Trial	PRODUCT NAME: METFORMIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; SAXAGLIPTIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; DAPAGLIFLOZIN ELLER ET FARMACEUTISK ACCEPTABELT SOLVAT DERAF; REG. NO/DATE: EU/1/19/1401 20191113
1506211	122014000071	Germany	⤷ Try a Trial	PRODUCT NAME: KOMBINATION VON DAPAGLIFLOZIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, UND METFORMIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, GESCHUETZT DURCH DAS GRUNDPATENT EP 1 506 211; REGISTRATION NO/DATE: EU/1/13/900 20140116
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.